In today’s dynamic regulatory landscape, understanding and mastering the Investigational New Drug (IND) application process is essential for pharmaceutical and biotechnology companies.   This webinar offers a comprehensive guide to navigating the key regulatory requirements under 21 CFR Part 312, ensuring successful IND submissions and ongoing compliance.   Led by regulatory experts Lara Stevanato, PhD, … Continued